Age-related changes in fibroblast cells promote pancreatic cancer growth and spread
New research shows that aging alters pancreatic fibroblasts in ways that enable them to promote pancreatic cancer tumor growth. …
New research shows that aging alters pancreatic fibroblasts in ways that enable them to promote pancreatic cancer tumor growth. …
Systematic review and meta-analysis of observational studies suggest that phytonutrients derived from soy, green tea, and other plants significantly reduce the risks in breast cancer outcomes. …
Modifying a specific protein in T cells can make them more robust, potentially improving cancer immunotherapy. …
An experimental drug that inhibits a gut enzyme protects mice from inflammatory bowel disease (IBD) symptoms and preserves barrier function in intestinal “organoids” derived from IBD patients. …
Deep-learning technology can accurately predict cancer-related protein fragments that may trigger an immune system response, which could overcome a major hurdle to developing personalized cancer immunotherapies and vaccines. …
Giving patients with operable pancreatic cancer a three-pronged combination immunotherapy treatment increases the amount of cancer-killing T cells in the tumors and appears effective when given prior to cancer-removal surgery. …
Preclinical study finds that epigallocatechin gallate (EGCG), a green tea compound with powerful antioxidant properties, could be promising for both treating and preventing uterine fibroids. …
Two new studies in mice with a humanized immune system and human cell lines have identified an enzyme that plays a critical role in the late stages of HIV replication. …
High levels of cell-free DNA circulating in blood is further linked to chronic inflammation, a well-known risk factor for severe aging symptoms and frailty in older adults. …
A microparticle-delivered therapy may be first step toward stopping multiple sclerosis and other autoimmune diseases. …
End of content
End of content